◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › M › MGNX

MacroGenics, Inc. (MGNX) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-10-31

MacroGenics, Inc. (MGNX) operates in the Biotechnology industry and is headquartered in Rockville, United States with about 293 employees. Its market capitalization is roughly $153 million. In the fiscal year ended 2025-12-31, MGNX reported $150M in revenue and ($75M) in net income.

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States.

Interactive charts & full statements → Open the MGNX valuation workbench →

MGNX Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$168M$150M$150M$59M$150M—
Gross Profit—$114M$138M$50M$143M—
Operating Income (EBIT)($41M)($73M)($111M)($168M)($121M)—
Net Income($15M)($75M)($67M)($9M)($120M)—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MGNX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$33M$21M$41M$73M$7M—
Gross Profit—$11M$31M$61M$13M$8M
Operating Income (EBIT)($14M)($33M)($12M)$19M($43M)—
Net Income$20M($37M)($14M)$17M($36M)—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MGNX Free Cash Flow History

MGNX Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$257M$262M$298M$280M—
Total Liabilities$201M$146M$146M$138M—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MGNX viewer.

Other Companies in Biotechnology

← MGNSAll “M” companiesMGOR →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.